Dr. Jennifer Dickey, PhD, RAC joined PGDx, a Labcorp company, in January 2017 and served as the Director of Regulatory Affairs and Quality. In January 2018, Dr. Dickey was promoted to the Vice President of Regulatory and Quality. Jennifer comes with an impressive background having been with the FDA as Senior Scientific Reviewer in the Molecular Genetics branch of the Office of In-Vitro Diagnostics and Radiological Health for 5 years.

Dr. Dickey has more than 15 years of regulatory review experience and was Regulatory Affairs Certified (RAC) through the Regulatory Affairs Professional Society (RAPS) in 2012. She has played a leadership role in several regulatory initiatives including serving as Chair of the Next Generation Sequencing-based Oncology Panels Public Workshop (February 25, 2016) and as lead reviewer for the first NGS-based assay. Dr. Dickey has spoken at several association conferences on subjects such as Regulatory Review of NGS Assays; Potential Roles for NGS in Companion Diagnostics; FDA Review of NGS Technologies; Multi-Analyte NGS Assays; and Enabling NGS in Global Clinical Trials, additionally Dr. Dickey has co-authored numerous peer-reviewed articles. Jennifer received her PhD in Biochemistry from Vanderbilt University.

Our leadership

Leadership team